Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Rockwell Medical (RMTI) over the last 10 years, with Q3 2025 value amounting to $1.2 million.

  • Rockwell Medical's Treasury Shares rose 11834.93% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 11834.93%. This contributed to the annual value of $584309.0 for FY2024, which is 12570.21% up from last year.
  • As of Q3 2025, Rockwell Medical's Treasury Shares stood at $1.2 million, which was up 11834.93% from $1.2 million recorded in Q2 2025.
  • Rockwell Medical's Treasury Shares' 5-year high stood at $1.2 million during Q2 2025, with a 5-year trough of $21612.0 in Q1 2021.
  • Moreover, its 5-year median value for Treasury Shares was $258885.0 (2023), whereas its average is $332177.3.
  • Per our database at Business Quant, Rockwell Medical's Treasury Shares plummeted by 9781.47% in 2021 and then skyrocketed by 34537.88% in 2023.
  • Over the past 5 years, Rockwell Medical's Treasury Shares (Quarter) stood at $29289.0 in 2021, then skyrocketed by 326.78% to $125000.0 in 2022, then soared by 107.11% to $258885.0 in 2023, then surged by 125.7% to $584309.0 in 2024, then skyrocketed by 99.66% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.2 million for Q2 2025, and $383326.0 during Q1 2025.